https://pharminent.com/strategic-news-watch/strategic-news-watch-october-2-2026/ 2026-10-02T15:45:52Z Pharminent en Strategic News Watch • October 2, 2026 2026-10-02T15:45:52Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-october-1-2026/ 2026-10-02T13:06:48Z Pharminent en Rare Disease & Gene Therapy Digest • October 1, 2026 2026-10-02T13:06:48Z Blog https://pharminent.com/novartis-signs-7-8b-abogen-deal-for-autoimmune-t-cell-engager/ 2026-10-02T11:45:53Z Pharminent en Novartis signs $7.8B Abogen deal for autoimmune T-cell engager 2026-10-02T11:45:53Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-october-1-2026/ 2026-10-01T14:30:24Z Pharminent en Strategic News Watch • October 1, 2026 2026-10-01T14:30:24Z Blog https://pharminent.com/sanofi-and-regeneron-expand-immunology-alliance-in-8b-deal/ 2026-10-01T11:45:59Z Pharminent en Sanofi and Regeneron expand immunology alliance in $8B deal 2026-10-01T11:45:59Z Blog